Davis CL - Search Results

1

Tacrolimus placental transfer at delivery and neonatal exposure through breast milk.

Zheng S, Easterling TR, Hays K, Umans JG, Miodovnik M, Clark S, Calamia JC, Thummel KE, Shen DD, Davis CL, Hebert MF. Zheng S, et al. Among authors: davis cl. Br J Clin Pharmacol. 2013 Dec;76(6):988-96. doi: 10.1111/bcp.12122. Br J Clin Pharmacol. 2013. PMID: 23528073 Free PMC article.

2

Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro.

Dai Y, Hebert MF, Isoherranen N, Davis CL, Marsh C, Shen DD, Thummel KE. Dai Y, et al. Among authors: davis cl. Drug Metab Dispos. 2006 May;34(5):836-47. doi: 10.1124/dmd.105.008680. Epub 2006 Feb 24. Drug Metab Dispos. 2006. PMID: 16501005

3

Pharmacokinetics of tacrolimus during pregnancy.

Zheng S, Easterling TR, Umans JG, Miodovnik M, Calamia JC, Thummel KE, Shen DD, Davis CL, Hebert MF. Zheng S, et al. Among authors: davis cl. Ther Drug Monit. 2012 Dec;34(6):660-70. doi: 10.1097/FTD.0b013e3182708edf. Ther Drug Monit. 2012. PMID: 23007747 Free PMC article.

4

Interpreting tacrolimus concentrations during pregnancy and postpartum.

Hebert MF, Zheng S, Hays K, Shen DD, Davis CL, Umans JG, Miodovnik M, Thummel KE, Easterling TR. Hebert MF, et al. Among authors: davis cl. Transplantation. 2013 Apr 15;95(7):908-15. doi: 10.1097/TP.0b013e318278d367. Transplantation. 2013. PMID: 23274970 Free PMC article. Review.

5

CYP3A5 gene variation influences cyclosporine A metabolite formation and renal cyclosporine disposition.

Zheng S, Tasnif Y, Hebert MF, Davis CL, Shitara Y, Calamia JC, Lin YS, Shen DD, Thummel KE. Zheng S, et al. Among authors: davis cl. Transplantation. 2013 Mar 27;95(6):821-7. doi: 10.1097/TP.0b013e31827e6ad9. Transplantation. 2013. PMID: 23354298 Free PMC article.

6

In vitro metabolism of cyclosporine A by human kidney CYP3A5.

Dai Y, Iwanaga K, Lin YS, Hebert MF, Davis CL, Huang W, Kharasch ED, Thummel KE. Dai Y, et al. Among authors: davis cl. Biochem Pharmacol. 2004 Nov 1;68(9):1889-902. doi: 10.1016/j.bcp.2004.07.012. Biochem Pharmacol. 2004. PMID: 15450954

7

Accurate prediction of dose-dependent CYP3A4 inhibition by itraconazole and its metabolites from in vitro inhibition data.

Templeton I, Peng CC, Thummel KE, Davis C, Kunze KL, Isoherranen N. Templeton I, et al. Clin Pharmacol Ther. 2010 Oct;88(4):499-505. doi: 10.1038/clpt.2010.119. Epub 2010 Aug 25. Clin Pharmacol Ther. 2010. PMID: 20739919 Free PMC article. Clinical Trial.

8

Evaluation of 6β-hydroxycortisol, 6β-hydroxycortisone, and a combination of the two as endogenous probes for inhibition of CYP3A4 in vivo.

Peng CC, Templeton I, Thummel KE, Davis C, Kunze KL, Isoherranen N. Peng CC, et al. Clin Pharmacol Ther. 2011 Jun;89(6):888-95. doi: 10.1038/clpt.2011.53. Epub 2011 Apr 13. Clin Pharmacol Ther. 2011. PMID: 21490593 Free PMC article.

9

Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease.

Smith HE, Jones JP 3rd, Kalhorn TF, Farin FM, Stapleton PL, Davis CL, Perkins JD, Blough DK, Hebert MF, Thummel KE, Totah RA. Smith HE, et al. Among authors: davis cl. Pharmacogenet Genomics. 2008 Nov;18(11):943-53. doi: 10.1097/FPC.0b013e32830e1e16. Pharmacogenet Genomics. 2008. PMID: 18769365 Free PMC article.

10

Simultaneous measurement of plasma vitamin D(3) metabolites, including 4β,25-dihydroxyvitamin D(3), using liquid chromatography-tandem mass spectrometry.

Wang Z, Senn T, Kalhorn T, Zheng XE, Zheng S, Davis CL, Hebert MF, Lin YS, Thummel KE. Wang Z, et al. Among authors: davis cl. Anal Biochem. 2011 Nov 1;418(1):126-33. doi: 10.1016/j.ab.2011.06.043. Epub 2011 Jul 13. Anal Biochem. 2011. PMID: 21784054 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

663 results

Search Page

Filters